Phase I and II studies with hexitol derivatives, formyl-leurosine and ftorafur.
作者信息
Eckhardt S
出版信息
Antibiot Chemother (1971). 1978;23:50-7. doi: 10.1159/000401471.
PMID:348087
Abstract
摘要
相似文献
1
Phase I and II studies with hexitol derivatives, formyl-leurosine and ftorafur.关于己糖醇衍生物、甲酰基长春罗新和替加氟的I期和II期研究。
Antibiot Chemother (1971). 1978;23:50-7. doi: 10.1159/000401471.
2
1,2:5,6-Dianhydrogalactitol in advanced breast cancer.1,2:5,6-二脱水半乳糖醇用于晚期乳腺癌
Cancer Treat Rep. 1978 May;62(5):841-2.
3
4
[New substances in oncologic therapy].
Dtsch Med Wochenschr. 1978 Jul 7;103(27):1087-92. doi: 10.1055/s-0028-1129206.
5
The effect of dibromo-dulcitol, diepoxy dulcitol and various new cytostatic hexitol derivatives on the metabolic activities of nucleic acids and proteins--II.二溴卫矛醇、双环氧卫矛醇及各种新型细胞生长抑制剂己糖醇衍生物对核酸和蛋白质代谢活性的影响——II
Biochem Pharmacol. 1976 Aug 1;25(15):1705-10. doi: 10.1016/0006-2952(76)90402-0.
6
Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.双去水半乳糖醇与依托泊苷（VP-16-213）用于结直肠癌的II期研究。
Cancer Treat Rep. 1976 Sep;60(9):1247-50.
7
Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
Gan To Kagaku Ryoho. 1985 Mar;12(3 Pt 2):783-8.
8
Anticancer chemotherapy.抗癌化疗
Br Med J (Clin Res Ed). 1983 Jul 9;287(6385):110-3. doi: 10.1136/bmj.287.6385.110.
9
The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcoma.细胞生长抑制剂己糖醇衍生物对造血干细胞、L1210白血病和C22LR骨肉瘤的作用。
Eur J Cancer (1965). 1975 Mar;11(3):169-73. doi: 10.1016/0014-2964(75)90112-7.
10
[Neurotoxicity of formyl leurosine. An experimental and clinical study (author's transl)].
Acta Neurol Belg. 1979 Jul-Aug;79(4):322-34.
引用本文的文献
1
Dominance of resistance to the alkylating agent 1,2:5,6-dianhydrogalactitol in P388 mouse lymphoma hybrid cells.
Cancer Chemother Pharmacol. 1989;23(1):41-6. doi: 10.1007/BF00258456.
Zotero 插件